{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:17:17Z","timestamp":1793171837845,"version":"4.5.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbadis.2023.166739","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T18:37:37Z","timestamp":1683139057000},"page":"166739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Advanced nanoscale drug delivery systems for bone cancer therapy"],"prefix":"10.1016","volume":"1869","author":[{"given":"Nazanin","family":"Amiryaghoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziyeh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaleh","family":"Barar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Omidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadollah","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166739_bb0010","author":"A. American Cancer Society"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s43046-021-00059-3","article-title":"Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview","volume":"33","author":"Desai","year":"2021","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2023.166739_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.673827","article-title":"Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis in osteosarcoma","volume":"9","author":"Qian","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0025","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2147\/IJN.S375950","article-title":"A selective reduction of osteosarcoma by mitochondrial apoptosis using hydroxyapatite nanoparticles","volume":"17","author":"Wu","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbadis.2023.166739_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586580","article-title":"Macrophages in osteosarcoma immune microenvironment: implications for immunotherapy","volume":"10","author":"Luo","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040976","article-title":"The osteosarcoma microenvironment: a complex but targetable ecosystem","volume":"9","author":"Corre","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166739_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fbioe.2020.00069","article-title":"Targeted drug delivery via the use of ECM-mimetic materials","volume":"8","author":"Hwang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/bmt-2019-0056","article-title":"Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma","volume":"65","author":"Xu","year":"2020","journal-title":"Biomed. Tech. (Berl.)"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/bios11020055","article-title":"Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma","volume":"11","author":"Barani","year":"2021","journal-title":"Biosensors (Basel)"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15171\/bi.2018.14","article-title":"Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells","volume":"8","author":"Aghanejad","year":"2018","journal-title":"Bioimpacts"},{"key":"10.1016\/j.bbadis.2023.166739_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijbiomac.2021.01.170","article-title":"Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer","volume":"174","author":"Nabi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/1061186X.2022.2055045","article-title":"Recent advances in nanoscale targeted therapy of HER2-positive breast cancer","volume":"30","author":"Omidi","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbadis.2023.166739_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111469","article-title":"MUC-1 aptamer conjugated InP\/ZnS quantum dots\/nanohydrogel fluorescent composite for mitochondria-mediated apoptosis in MCF-7 cells","volume":"118","author":"Ranjbar-Navazi","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.bbadis.2023.166739_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2018.02.027","article-title":"Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer","volume":"117","author":"Vandghanooni","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166739_bb0080","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2217\/nnm-2018-0205","article-title":"AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells","volume":"13","author":"Vandghanooni","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.bbadis.2023.166739_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118729","article-title":"Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells","volume":"573","author":"Vandghanooni","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166739_bb0090","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/adma.200400771","article-title":"Silica particles: a novel drug-delivery system","volume":"16","author":"Barb\u00e9","year":"2004","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0095","first-page":"135","article-title":"Targeted drug delivery system: a review","volume":"1","author":"Manish","year":"2011","journal-title":"Res. J. Chem. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0100","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-018-06979-4","article-title":"Cloaking nanoparticles with protein corona shield for targeted drug delivery","volume":"9","author":"Oh","year":"2018","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166739_bb0105","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1039\/c2nr31715j","article-title":"Biomedical nanomaterials for imaging-guided cancer therapy","volume":"4","author":"Huang","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbadis.2023.166739_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2023.166739_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.colsurfb.2016.07.060","article-title":"Multi-functional vesicles for cancer therapy: the ultimate magic bullet","volume":"147","author":"Tavano","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"41","key":"10.1016\/j.bbadis.2023.166739_bb0130","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.2174\/138161281941131219124142","article-title":"Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review","volume":"19","author":"Maya","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166739_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/21691401.2013.856016","article-title":"Stimuli-sensitive systems\u2013an emerging delivery system for drugs","volume":"43","author":"Bhardwaj","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166739_bb0140","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2217\/nnm-2021-0094","article-title":"Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted therapy","volume":"16","author":"Dolatkhah","year":"2021","journal-title":"Nanomedicine (Lond.)"},{"issue":"22","key":"10.1016\/j.bbadis.2023.166739_bb0145","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2217\/nnm-2020-0146","article-title":"Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors","volume":"15","author":"Fathi","year":"2020","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.bbadis.2023.166739_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.talanta.2018.09.023","article-title":"Ultra-sensitive detection by metal nanoparticles-mediated enhanced SPR biosensors","volume":"192","author":"Fathi","year":"2019","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15171\/bi.2017.32","article-title":"Stimuli-responsive chitosan-based nanocarriers for cancer therapy","volume":"7","author":"Fathi","year":"2017","journal-title":"Bioimpacts"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166739_bb0160","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/03639045.2017.1313859","article-title":"Fluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery","volume":"43","author":"Shakoori","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166739_bb0165","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1039\/b923947b","article-title":"Responsive reversible hydrogels from associative \u201csmart\u201d macromolecules","volume":"6","author":"Tsitsilianis","year":"2010","journal-title":"Soft Matter"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10965-012-9822-8","article-title":"Photopolymerised thermo-responsive poly(N, N-diethylacrylamide)-based copolymer hydrogels for potential drug delivery applications","volume":"19","author":"Ngadaonye","year":"2012","journal-title":"J. Polym. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2009.10.011","article-title":"Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs","volume":"142","author":"Suedee","year":"2010","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0180","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1166\/jnn.2015.10325","article-title":"Cancer targeting: responsive polymers for stimuli-sensitive drug delivery","volume":"15","author":"Bhatnagar","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: static and dynamic targeting strategies","volume":"327","author":"Moradi Kashkooli","year":"2020","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/os.12238","article-title":"Advances in bone-targeted drug delivery systems for neoadjuvant chemotherapy for osteosarcoma","volume":"8","author":"Li","year":"2016","journal-title":"Orthop. Surg."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166739_bb0195","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1158\/2326-6066.CIR-15-0194","article-title":"Reducing toxicity of immune therapy using aptamer-targeted drug delivery","volume":"3","author":"Gilboa","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/thno.10257","article-title":"Aptamers: active targeting ligands for cancer diagnosis and therapy","volume":"5","author":"Wu","year":"2015","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15171\/bi.2017.15","article-title":"Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy","volume":"7","author":"Asgharzadeh","year":"2017","journal-title":"Bioimpacts"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0215","first-page":"149","article-title":"Dysregulated pH in tumor microenvironment checkmates cancer therapy","volume":"3","author":"Barar","year":"2013","journal-title":"Bioimpacts"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0220","first-page":"55","article-title":"Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines","volume":"4","author":"Omidi","year":"2014","journal-title":"Bioimpacts"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020056","article-title":"Cancer stem cells, bone and tumor microenvironment: key players in bone metastases","volume":"10","author":"Roato","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11914-016-0315-2","article-title":"The bone microenvironment: a fertile soil for tumor growth","volume":"14","author":"Buenrostro","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bbadis.2023.166739_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-35727-6_1","article-title":"Novel techniques to study the bone-tumor microenvironment","volume":"1225","author":"Shupp","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110891","article-title":"Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma","volume":"190","author":"Huang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"43","key":"10.1016\/j.bbadis.2023.166739_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703932","article-title":"Fabrication of chitosan-18\u03b2-glycyrrhetinic acid modified titanium implants with nanorod arrays for suppression of osteosarcoma growth and improvement of osteoblasts activity","volume":"27","author":"Zhang","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.34172\/bi.2022.23904","article-title":"Injectable thermosensitive chitosan\/gelatin hydrogel for dental pulp stem cells proliferation and differentiation","volume":"13","author":"Samiei","year":"2023","journal-title":"Bioimpacts"},{"key":"10.1016\/j.bbadis.2023.166739_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2022.105313","article-title":"Hydrogel-based scaffolds for bone and cartilage tissue engineering and regeneration","volume":"177","author":"Amiryaghoubi","year":"2022","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.bbadis.2023.166739_bb0260","series-title":"Magnetic Nanoparticle-based Hybrid Materials","first-page":"183","article-title":"Magnetic nanoparticle-polymer nanohybrids","author":"Fathi","year":"2021"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166739_bb0265","doi-asserted-by":"crossref","first-page":"E264","DOI":"10.1111\/aor.13474","article-title":"Graphene oxide incorporated polycaprolactone\/chitosan\/collagen electrospun scaffold: enhanced osteogenic properties for bone tissue engineering","volume":"43","author":"Aidun","year":"2019","journal-title":"Artif. Organs"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00396-023-05066-5","article-title":"Chitosan\/gelatin hybrid nanogel containing doxorubicin as enzyme-responsive drug delivery system for breast cancer treatment","volume":"301","author":"Aslzad","year":"2023","journal-title":"Colloid Polym. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0275","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s42114-020-00154-4","article-title":"Bio-evaluation of doxorubicin (DOX)-incorporated hydroxyapatite (HAp)-chitosan (CS) nanocomposite triggered on osteosarcoma cells","volume":"3","author":"Ghosh","year":"2020","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166739_bb0280","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.biomaterials.2009.03.022","article-title":"A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biomaterials.2009.09.069","article-title":"The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model","volume":"31","author":"Tan","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2023.166739_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2021.108138","article-title":"Engineering PDA-coated CM-CS nanoparticles for photothermo-chemotherapy of osteosarcoma and bone regeneration","volume":"175","author":"Sun","year":"2021","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.bbadis.2023.166739_bb0295","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.msec.2017.12.024","article-title":"pH-responsive mesoporous ZSM-5 zeolites\/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma","volume":"85","author":"Yang","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.bbadis.2023.166739_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117680","article-title":"Magnetic bioactive glasses\/Cisplatin loaded-chitosan (CS)-grafted- poly (epsilon-caprolactone) nanofibers against bone cancer treatment","volume":"258","author":"Amini","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbadis.2023.166739_bb0305","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.biopha.2017.04.004","article-title":"Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma","volume":"90","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166739_bb0310","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/acsomega.8b02090","article-title":"Cisplatin-loaded graphene oxide\/chitosan\/hydroxyapatite composite as a promising tool for osteosarcoma-affected bone regeneration","volume":"3","author":"Sumathra","year":"2018","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0315","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jcp.1041530205","article-title":"Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells","volume":"153","author":"Andrianarivo","year":"1992","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0320","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7785\/tcrt.2012.500331","article-title":"Collagen-hydroxyapatite\/cisplatin drug delivery systems for locoregional treatment of bone cancer","volume":"12","author":"Andronescu","year":"2013","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.21082","article-title":"Engineering biodegradable polyester particles with specific drug targeting and drug release properties","volume":"97","author":"Mohamed","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0330","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jbm.a.35547","article-title":"Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy","volume":"104","author":"Floyd","year":"2016","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2023.166739_bb0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2016.03.002","article-title":"In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy","volume":"503","author":"Wang","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0340","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S2095-3119(17)61763-5","article-title":"Release performance and sustained-release efficacy of emamectin benzoate-loaded polylactic acid microspheres","volume":"17","author":"Yin","year":"2018","journal-title":"J. Integr. Agric."},{"key":"10.1016\/j.bbadis.2023.166739_bb0345","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.matlet.2017.09.089","article-title":"Facile fabrication of polylactic acid stereocomplex microspheres","volume":"211","author":"Chen","year":"2018","journal-title":"Mater. Lett."},{"key":"10.1016\/j.bbadis.2023.166739_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.supflu.2021.105462","article-title":"Synthesis of curcumin and indocyanine green co-loaded PLLA microparticles via solution-enhanced dispersion using supercritical CO2 for chemo-photothermal therapy of osteosarcoma","volume":"180","author":"Xiao","year":"2022","journal-title":"J. Supercrit. Fluids"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0355","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0360","doi-asserted-by":"crossref","first-page":"17387","DOI":"10.1038\/srep17387","article-title":"Development of alendronate-conjugated poly (lactic-co-glycolic acid)-dextran nanoparticles for active targeting of cisplatin in osteosarcoma","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0365","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12885-015-1735-6","article-title":"Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in osteosarcoma","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166739_bb0370","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/jbm.a.34550","article-title":"Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells","volume":"101","author":"Maran","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.bbadis.2023.166739_bb0375","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jddst.2019.05.027","article-title":"Dual-functional melatonin releasing device loaded with PLGA microparticles and cyclodextrin inclusion complex for osteosarcoma therapy","volume":"52","author":"\u00c7etin Alt\u0131ndal","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0380","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1166\/jnn.2020.17689","article-title":"Biomedical application of doxorubicin coated hydroxyapatite-poly(lactide-co-glycolide) nanocomposite for controlling osteosarcoma therapeutics","volume":"20","author":"Ghosh","year":"2020","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0385","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4314\/tjpr.v15i7.1","article-title":"Development of docetaxel and alendronate-loaded chitosan-conjugated polylactide-co-glycolide nanoparticles: in vitro characterization in osteosarcoma cells","volume":"15","author":"Liu","year":"2016","journal-title":"Trop. J. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0390","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/coatings12040524","article-title":"Supercritical fluid-assisted fabrication of PDA-coated poly (l-lactic Acid)\/curcumin microparticles for chemo-photothermal therapy of osteosarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Coatings"},{"key":"10.1016\/j.bbadis.2023.166739_bb0395","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fmats.2021.668834","article-title":"The application of 3D-printing and nanotechnology for the targeted treatment of osteosarcoma","volume":"8","author":"Suleman","year":"2021","journal-title":"Front. Mater."},{"key":"10.1016\/j.bbadis.2023.166739_bb0400","series-title":"Film Properties of Plastics and Elastomers","author":"McKeen","year":"2017"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0405","article-title":"Cisplatin loaded polycaprolactone \u2013 zeolite nanocomposite scaffolds for bone cancer treatment","volume":"7","author":"Zakeri","year":"2022","journal-title":"J. Sci.-Adv. Mater. Dev."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0410","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1166\/jbn.2021.3060","article-title":"Cisplatin loaded poly(L-glutamic acid)-g-methoxy polyethylene glycol complex nanoparticles combined with gemcitabine presents improved safety and lasting anti-tumor efficacy in a murine xenograft model of human aggressive B cell lymphoma","volume":"17","author":"Liu","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"issue":"30","key":"10.1016\/j.bbadis.2023.166739_bb0415","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1016\/j.biomaterials.2014.06.045","article-title":"PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment","volume":"35","author":"Ma","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2023.166739_bb0420","series-title":"Biotreatment of Industrial Effluents","author":"Doble","year":"2005"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166739_bb0425","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/10601320701283610","article-title":"Feasibility of polyvinyl alcohol as a transdermal drug delivery system for terbutaline sulphate","volume":"44","author":"Kumar","year":"2007","journal-title":"J. Macromol. Sci. A"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0430","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.crci.2018.10.005","article-title":"Development and physicochemical characterization of doxorubicin-encapsulated hydroxyapatite\u2013polyvinyl alcohol nanocomposite for repair of osteosarcoma-affected bone tissues","volume":"22","author":"Ghosh","year":"2019","journal-title":"C. R. Chim"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166739_bb0435","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s12221-020-9809-8","article-title":"Incorporation of hydroxyapatite\/doxorubicin into the chitosan\/polyvinyl alcohol\/polyurethane nanofibers for controlled release of doxurubicin and its anticancer property","volume":"21","author":"Qavamnia","year":"2020","journal-title":"Fiber Polym."},{"key":"10.1016\/j.bbadis.2023.166739_bb0440","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jddst.2019.03.041","article-title":"Hydroxyapatite-poly(vinyl alcohol) core-shell nanoparticles for dual delivery of methotrexate and gemcitabine for bone cancer treatment","volume":"51","author":"Ram Prasad","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0445","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2147\/IJN.S257084","article-title":"Efficient miRNA inhibitor with GO-PEI nanosheets for osteosarcoma suppression by targeting PTEN","volume":"15","author":"Ou","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.bbadis.2023.166739_bb0450","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3390\/molecules23123122","article-title":"The degradation products of ascorbic acid inhibit amyloid fibrillation of insulin and destabilize preformed fibrils","volume":"23","author":"Yang","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0455","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijbiomac.2011.04.007","article-title":"Dextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells","volume":"49","author":"Sun","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0460","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/nnm-2019-0218","article-title":"Polyethylenimine-dextran-coated magnetic nanoparticles loaded with miR-302b suppress osteosarcoma in vitro and in vivo","volume":"15","author":"Gong","year":"2020","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s11671-019-2882-5","article-title":"Improving magnetofection of magnetic polyethylenimine nanoparticles into MG-63 osteoblasts using a novel uniform magnetic field","volume":"14","author":"Cen","year":"2019","journal-title":"Nanoscale Res. Lett."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0470","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40097-018-0265-6","article-title":"Graphene and graphene oxide as nanomaterials for medicine and biology application","volume":"8","author":"Priyadarsini","year":"2018","journal-title":"J. Nanostruct. Chem."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166739_bb0475","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/ar300159f","article-title":"Biomedical applications of graphene and graphene oxide","volume":"46","author":"Chung","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbadis.2023.166739_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111554","article-title":"Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells","volume":"119","author":"Niu","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"19","key":"10.1016\/j.bbadis.2023.166739_bb0485","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.1039\/C5RA25518J","article-title":"Co-delivery of paclitaxel and indocyanine green by PEGylated graphene oxide: a potential integrated nanoplatform for tumor theranostics","volume":"6","author":"Zhang","year":"2016","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0490","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/nano11030611","article-title":"You don't learn that in school: an updated practical guide to carbon quantum dots","volume":"11","author":"Sousa","year":"2021","journal-title":"Nanomaterials (Basel)"},{"issue":"21","key":"10.1016\/j.bbadis.2023.166739_bb0495","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.3390\/ijms232113283","article-title":"Fighting non-small lung cancer cells using optimal functionalization of targeted carbon quantum dots derived from natural sources might provide potential therapeutic and cancer bio image strategies","volume":"23","author":"El-Brolsy","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166739_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.882100","article-title":"A strategic review on carbon quantum dots for cancer-diagnostics and treatment","volume":"10","author":"Naik","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0505","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.carbon.2017.03.085","article-title":"Near-infrared light triggered photo-therapy, in combination with chemotherapy using magnetofluorescent carbon quantum dots for effective cancer treating","volume":"118","author":"Zhang","year":"2017","journal-title":"Carbon"},{"key":"10.1016\/j.bbadis.2023.166739_bb0510","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2846297","article-title":"Triggering of apoptosis in osteosarcoma 143B cell line by carbon quantum dots via the mitochondrial apoptotic signal pathway","volume":"2020","author":"Jiao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2023.166739_bb0515","series-title":"14th IEEE International Conference on Nanotechnology","first-page":"672","article-title":"Engineering large gelatin nanospheres coated with quantum dots for targeted delivery of human osteosarcoma with enhanced cellular internalization","author":"Tse","year":"2014"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0520","first-page":"721","article-title":"Calcium-mineralized polypeptide nanoparticle for intracellular drug delivery in osteosarcoma chemotherapy","volume":"5","author":"Li","year":"2020","journal-title":"Bioact. Mater."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166739_bb0525","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.7150\/thno.46662","article-title":"Erratum: sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished pulmonary metastasis: erratum","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0530","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1080\/10717544.2020.1856221","article-title":"Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma","volume":"27","author":"Qiu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbadis.2023.166739_bb0535","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jddst.2015.08.004","article-title":"Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells","volume":"30","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0540","first-page":"1320","article-title":"Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL","volume":"57","author":"Mollinedo","year":"1997","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166739_bb0545","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/nnm.11.134","article-title":"Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles","volume":"7","author":"Estella-Hermoso de Mendoza","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.bbadis.2023.166739_bb0550","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canlet.2018.05.030","article-title":"Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma","volume":"430","author":"Gonzalez-Fernandez","year":"2018","journal-title":"Cancer Lett."},{"issue":"26","key":"10.1016\/j.bbadis.2023.166739_bb0555","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1039\/C5CC00482A","article-title":"Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan","volume":"51","author":"Ramasamy","year":"2015","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.bbadis.2023.166739_bb0560","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.colsurfb.2017.08.042","article-title":"Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma","volume":"159","author":"Duan","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0565","first-page":"53","article-title":"Study on osteosarcoma targeting of solid lipid nanoparticles modified with peptides specifically binding to human osteosarcoma cells","volume":"37","author":"Song","year":"2014","journal-title":"Chin. J. Biotechnol. Pharm."},{"issue":"45","key":"10.1016\/j.bbadis.2023.166739_bb0570","doi-asserted-by":"crossref","first-page":"17726","DOI":"10.1039\/C9NJ01634A","article-title":"Lipid nanoparticles \u2013 metvan: revealing a novel way to deliver a vanadium compound to bone cancer cells","volume":"43","author":"Cacicedo","year":"2019","journal-title":"New J. Chem."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166739_bb0575","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.sjbs.2016.12.001","article-title":"Ifosfamide-loaded lipid-core-nanocapsules to increase the anticancer efficacy in MG63 osteosarcoma cells","volume":"25","author":"Wang","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166739_bb0580","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-021-03915-1","article-title":"Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0585","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7150\/thno.30853","article-title":"Design strategies and application progress of therapeutic exosomes","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0590","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1083\/jcb.97.2.329","article-title":"Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes","volume":"97","author":"Harding","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0595","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bios.2016.12.062","article-title":"Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: current status and future directions","volume":"91","author":"Gholizadeh","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bbadis.2023.166739_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.737314","article-title":"Exosomes as efficient nanocarriers in osteosarcoma: biological functions and potential clinical applications","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0605","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2147\/IJN.S372851","article-title":"Mesenchymal stem cell derived exosomes as nanodrug carrier of doxorubicin for targeted osteosarcoma therapy via SDF1-CXCR4 axis","author":"Wei","year":"2022","journal-title":"Int.J. Nanomed."},{"key":"10.1016\/j.bbadis.2023.166739_bb0610","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.2147\/IJN.S218988","article-title":"A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro","volume":"14","author":"Wei","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0615","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/pharmaceutics15010220","article-title":"Advances in the study of exosomes as drug delivery systems for bone-related diseases","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbadis.2023.166739_bb0620","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.omtn.2020.07.025","article-title":"Exosomal transfer of LCP1 promotes osteosarcoma cell tumorigenesis and metastasis by activating the JAK2\/STAT3 signaling pathway","volume":"21","author":"Ge","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0625","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1080\/10717544.2022.2141921","article-title":"Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0630","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/07388551.2016.1185389","article-title":"Chitosan magnetic nanoparticles for drug delivery systems","volume":"37","author":"Assa","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0635","article-title":"Preparation and in-vitro evaluation of pH-responsive cationic cyclodextrin coated magnetic nanoparticles for delivery of methotrexate to the Saos-2 bone cancer cells","volume":"57","author":"Ahmadi","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0640","series-title":"Biopolymer-based Nanomaterials in Drug Delivery and Biomedical Applications","first-page":"221","article-title":"Hyaluronic acid-based nanosystems for drug delivery applications","author":"K\u0142odzi\u0144ska","year":"2021"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166739_bb0645","article-title":"Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma","volume":"5","author":"Zhang","year":"2018","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"14","key":"10.1016\/j.bbadis.2023.166739_bb0650","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/polym13142302","article-title":"Photocuring hyaluronic acid\/silk fibroin hydrogel containing curcumin loaded chitosan nanoparticles for the treatment of MG-63 cells and ME3T3-E1 cells","volume":"13","author":"Yu","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.bbadis.2023.166739_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2021.125146","article-title":"Fabrication of bone-targeting hyaluronic acid coupled alendronate-bioactive glass for osteosarcoma therapy","volume":"273","author":"Mehnath","year":"2021","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.bbadis.2023.166739_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112911","article-title":"Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells","volume":"220","author":"Amiryaghoubi","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbadis.2023.166739_bb0665","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fchem.2019.00167","article-title":"Gold nanoparticles for photothermal cancer therapy","volume":"7","author":"Vines","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbadis.2023.166739_bb0670","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/IJN.S184723","article-title":"A review of small molecules and drug delivery applications using gold and iron nanoparticles","volume":"14","author":"Jahangirian","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbadis.2023.166739_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111778","article-title":"Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal","volume":"203","author":"Chakraborty","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0680","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1038\/s41598-020-63245-8","article-title":"Effect of TAT-DOX-PEG irradiated gold nanoparticles conjugates on human osteosarcoma cells","volume":"10","author":"Lupusoru","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166739_bb0685","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.3390\/molecules26123487","article-title":"Enhanced cytotoxic effect of doxorubicin conjugated to glutathione-stabilized gold nanoparticles in canine osteosarcoma-in vitro studies","volume":"26","author":"Malek","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2023.166739_bb0690","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.colsurfb.2017.07.006","article-title":"Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells","volume":"158","author":"Meshkini","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbadis.2023.166739_bb0695","article-title":"Osteogenic biomaterials in contemporary dentistry","volume":"2015","author":"Kim","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2023.166739_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.surfcoat.2020.125793","article-title":"Effects of vitamin C on osteoblast proliferation and osteosarcoma inhibition using plasma coated hydroxyapatite on titanium implants","volume":"394","author":"Sarkar","year":"2020","journal-title":"Surf. Coat. Technol."},{"issue":"23","key":"10.1016\/j.bbadis.2023.166739_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901031","article-title":"Fabrication of curcumin-modified TiO(2) nanoarrays via cyclodextrin based polymer functional coatings for osteosarcoma therapy","volume":"8","author":"Zhang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0710","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1515\/rams-2019-0010","article-title":"Ceramics-based drug delivery system: a review and outlook","volume":"58","author":"Zang","year":"2019","journal-title":"Rev. Adv. Mater. Sci."},{"key":"10.1016\/j.bbadis.2023.166739_bb0715","first-page":"2713","article-title":"Multifunctional materials for bone cancer treatment","volume":"9","author":"Marques","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbadis.2023.166739_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110096","article-title":"Sustained release of vitamin C from PCL coated TCP induces proliferation and differentiation of osteoblast cells and suppresses osteosarcoma cell growth","volume":"105","author":"Bose","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0725","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aba7d5","article-title":"Fe(3)O(4)\/bioactive glass nanostructure: a promising therapeutic platform for osteosarcoma treatment","volume":"16","author":"Sabouri","year":"2021","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.bbadis.2023.166739_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109994","article-title":"Mesoporous bioactive glasses for the combined application of osteosarcoma treatment and bone regeneration","volume":"104","author":"Ravanbakhsh","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166739_bb0735","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1039\/c3tb20275e","article-title":"Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells","volume":"1","author":"Wu","year":"2013","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0740","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1364\/BOE.1.000453","article-title":"Folate receptor targeting silica nanoparticle probe for two-photon fluorescence bioimaging","volume":"1","author":"Wang","year":"2010","journal-title":"Biomed. Opt. Express"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166739_bb0745","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines.Physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40824-017-0099-1","article-title":"Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma","volume":"21","author":"Son","year":"2017","journal-title":"Biomater. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0755","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00776-011-0045-3","article-title":"Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma","volume":"16","author":"Tanzawa","year":"2011","journal-title":"J. Orthop. Sci."},{"issue":"40","key":"10.1016\/j.bbadis.2023.166739_bb0760","doi-asserted-by":"crossref","first-page":"45156","DOI":"10.1021\/acsami.2c12102","article-title":"Cancer inhibition and in vivo osteointegration and compatibility of gallium-doped bioactive glasses for osteosarcoma applications","volume":"14","author":"Souza","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"18","key":"10.1016\/j.bbadis.2023.166739_bb0765","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1007\/s12633-022-01957-4","article-title":"Processing and characterization of gallium-modified bioactive glass nanoparticles for controlled delivery of 5-fluorouracil and vitamin D3: an advanced approach to osteoporosis and bone cancer treatment","volume":"14","author":"Ali","year":"2022","journal-title":"SILICON"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0770","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/1061186X.2019.1616745","article-title":"Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer","volume":"28","author":"Siminzar","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbadis.2023.166739_bb0775","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrgentox.2014.05.009","article-title":"Biocompatibility of core@shell particles: cytotoxicity and genotoxicity in human osteosarcoma cells of colloidal silica spheres coated with crystalline or amorphous zirconia","volume":"770","author":"Di Virgilio","year":"2014","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"19","key":"10.1016\/j.bbadis.2023.166739_bb0780","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800602","article-title":"Enhancing osteosarcoma killing and CT imaging using ultrahigh drug loading and NIR-responsive bismuth sulfide@mesoporous silica nanoparticles","volume":"7","author":"Lu","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166739_bb0785","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1039\/D0NR09220G","article-title":"Manganese-doped gold core mesoporous silica particles as a nanoplatform for dual-modality imaging and chemo-chemodynamic combination osteosarcoma therapy","volume":"13","author":"Sha","year":"2021","journal-title":"Nanoscale"},{"issue":"19","key":"10.1016\/j.bbadis.2023.166739_bb0790","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.biomaterials.2012.03.033","article-title":"The biocompatibility and antibacterial properties of collagen-stabilized, photochemically prepared silver nanoparticles","volume":"33","author":"Alarcon","year":"2012","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166739_bb0795","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1021\/nn4050744","article-title":"Insights into the cellular response triggered by silver nanoparticles using quantitative proteomics","volume":"8","author":"Verano-Braga","year":"2014","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166739_bb0800","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1021\/nn102272n","article-title":"Controlled release of biologically active silver from nanosilver surfaces","volume":"4","author":"Liu","year":"2010","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0805","doi-asserted-by":"crossref","first-page":"27902","DOI":"10.1038\/srep27902","article-title":"Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis","volume":"6","author":"Kovacs","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166739_bb0810","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1016\/j.ceramint.2020.01.086","article-title":"Osteogenic silver oxide doped mesoporous bioactive glass for controlled release of doxorubicin against bone cancer cell line (MG-63): in vitro and in vivo cytotoxicity evaluation","volume":"46","author":"ur Rahman","year":"2020","journal-title":"Ceram. Int."},{"issue":"17","key":"10.1016\/j.bbadis.2023.166739_bb0815","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.7150\/thno.45858","article-title":"Fructose-coated angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166739_bb0820","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/nano9081089","article-title":"Tangeretin-assisted platinum nanoparticles enhance the apoptotic properties of doxorubicin: combination therapy for osteosarcoma treatment","volume":"9","author":"Gurunathan","year":"2019","journal-title":"Nanomaterials (Basel)"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166739_bb0825","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tranon.2019.10.012","article-title":"Bone metastasis: current state of play","volume":"13","author":"Turpin","year":"2020","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166739_bb0830","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/ma11091485","article-title":"Nanoporous 3D-printed scaffolds for local doxorubicin delivery in bone metastases secondary to prostate cancer","volume":"11","author":"Ahangar","year":"2018","journal-title":"Materials (Basel)"},{"issue":"12","key":"10.1016\/j.bbadis.2023.166739_bb0835","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/j.1742-4658.2012.08607.x","article-title":"Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling","volume":"279","author":"Li","year":"2012","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0840","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abf7d5","article-title":"Nanocarrier-based drug delivery systems for bone cancer therapy: a review","volume":"16","author":"Prasad","year":"2021","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.bbadis.2023.166739_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115492","article-title":"Targeting anti-cancer agents to bone using bisphosphonates","volume":"138","author":"Xing","year":"2020","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166739_bb0850","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ml5004603","article-title":"Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters","volume":"6","author":"Puljula","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2023.166739_bb0855","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2018.03.010","article-title":"Targeting therapeutics to bone by conjugation with bisphosphonates","volume":"40","author":"Young","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166739_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.111875","article-title":"Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma","volume":"121","author":"Quadros","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"Suppl 1","key":"10.1016\/j.bbadis.2023.166739_bb0865","first-page":"99","article-title":"Preparation and characterization of an iron oxide-hydroxyapatite nanocomposite for potential bone cancer therapy","volume":"10 Suppl 1","author":"Sneha","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbadis.2023.166739_bb0870","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.msec.2019.02.047","article-title":"Graphene oxide functionalized with chitosan based nanoparticles as a carrier of siRNA in regulating Bcl-2 expression on Saos-2 & MG-63 cancer cells and its inflammatory response on bone marrow derived cells from mice","volume":"99","author":"Saravanabhavan","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0875","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10876-022-02235-4","article-title":"Anticancer drug-loading capacity of green synthesized porous magnetic iron nanocarrier and cytotoxic effects against human cancer cell line","volume":"34","author":"Ansari","year":"2022","journal-title":"J. Clust. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0880","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12951-022-01364-2","article-title":"Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms","volume":"20","author":"Kaushik","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166739_bb0885","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1039\/c3tb00536d","article-title":"Bionanomaterials for bone tumor engineering and tumor destruction","volume":"1","author":"Blackburn","year":"2013","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0890","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7150\/jca.36588","article-title":"Recent advances of drug delivery nanocarriers in osteosarcoma treatment","volume":"11","author":"Wang","year":"2020","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166739_bb0895","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/17425247.2016.1156671","article-title":"Biodegradable polymers for targeted delivery of anti-cancer drugs","volume":"13","author":"Doppalapudi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166739_bb0900","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jfb10010004","article-title":"Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies","volume":"10","author":"Calzoni","year":"2019","journal-title":"J. Funct. Biomater."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T01:59:35Z","timestamp":1722563975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":179,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0925443923001059"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166739","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced nanoscale drug delivery systems for bone cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166739"}}